<p>The Nasdaq Biotechnology Index closed up over 3%, outperforming the broader U.S. stock market indices.
Component stock Monte Rosa Therapeutics led the way with a gain of 45.41%, followed by Erasca up 42.15%, Ventyx Biosciences up 36.62%, and Revolution Med, GH Research, Neumora Therapeutics, Immuneering, and Tango Therapeutics rising between 28.63% and 22.21%.
Ironwood Pharmaceuticals saw a decline of 5.30%, the third largest drop, while Gossamer Bio fell 5.86% and Arrowhead Pharmaceuticals dropped 7.23%</p>

ERAS

VTYX

GLUE

<p>The Nasdaq Biotechnology Index rose more than 3%, outperforming the broader U.S. stock market. Monte Rosa Therapeutics led the gains, up 45.41%; Erasca rose 42.15%; Ventyx Biosciences increased by 36.62%. Revolution Med, GH Research, Neumora Therapeutics, Immuneering, and Tango Therapeutics saw gains between 22.21% and 28.63%. Ironwood Pharmaceuticals fell 5.30%, Gossamer Bio dropped 5.86%, and Arrowhead Pharmaceuticals decreased by 7.23%</p>

News